Sanara Medtech Inc reports results for the quarter ended in March - Earnings Summary

Sanara MedTech

15/05/2023 23:46

* Sanara Medtech Inc  SMTI.OQ  reported a quarterly adjusted
loss
of 14 cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 33 cents per
share.
    * Revenue rose 98.7% to $15.52 million from a year ago;
analysts
expected $16.20 million. 
    * Sanara Medtech Inc's reported EPS for the quarter was a
loss
of 14 cents​.
    * The mean earnings estimate of analysts had fallen by
about 175%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sanara Medtech Inc shares had fallen by 0.5% this
quarter and
lost 9.8% so far this year.
    * The company reported a quarterly loss of $1.18 million.
    * Wall Street's median 12-month price target for Sanara
Medtech
Inc is $60.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 10:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.33          -0.14          Beat
 Dec. 31 2022      -0.26          -0.38          Missed
 Sep. 30 2022      -0.32          -0.18          Beat
 Jun. 30 2022      -0.28          -0.42          Missed